ストックスクリーナーアプリを入手
1.58
1.28%
0.02
前日終値:
$1.56
開ける：
$1.49
24時間の取引高:
1.05M
Relative Volume:
0.89
時価総額：
$99.68M
収益：
$139.77M
当期純損益:
$-97.62M
株価収益率:
-1.00
EPS:
-1.58
ネットキャッシュフロー:
$-61.71M
1週間 パフォーマンス:
-7.60%
1か月 パフォーマンス:
+25.40%
6か月 パフォーマンス:
-47.33%
1年 パフォーマンス:
-60.50%
1日の値動き範囲:
$1.49
$1.62
1週間の範囲:
$1.47
$1.76
52週間の値動き範囲:
$0.9897
$5.10
Macrogenics Inc Stock (MGNX) Company Profile
名前
Macrogenics Inc
セクター
電話
301-251-5172
住所
9704 MEDICAL CENTER DRIVE, Rockville, MD
MGNX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MGNX
Macrogenics Inc
|
1.58 | 98.42M | 139.77M | -97.62M | -61.71M | -1.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Macrogenics Inc Stock (MGNX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-07 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-01 | ダウングレード | BTIG Research | Buy → Neutral |
| 2024-07-31 | ダウングレード | B. Riley Securities | Buy → Neutral |
| 2024-07-31 | ダウングレード | Guggenheim | Buy → Neutral |
| 2024-05-10 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2024-05-10 | ダウングレード | Stifel | Buy → Hold |
| 2024-05-10 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-04-26 | 開始されました | B. Riley Securities | Buy |
| 2024-04-09 | アップグレード | TD Cowen | Hold → Buy |
| 2024-03-04 | 繰り返されました | BTIG Research | Buy |
| 2024-02-14 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-12-20 | アップグレード | Citigroup | Neutral → Buy |
| 2023-11-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2023-03-17 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-11-22 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-11-14 | アップグレード | BMO Capital Markets | Market Perform → Outperform |
| 2022-07-18 | ダウングレード | SMBC Nikko | Outperform → Neutral |
| 2022-07-11 | ダウングレード | BMO Capital Markets | Outperform → Market Perform |
| 2022-05-04 | ダウングレード | Guggenheim | Buy → Neutral |
| 2022-02-28 | アップグレード | Citigroup | Neutral → Buy |
| 2022-02-11 | 開始されました | BMO Capital Markets | Outperform |
| 2022-02-04 | 開始されました | SMBC Nikko | Outperform |
| 2021-11-17 | 再開されました | Guggenheim | Buy |
| 2021-10-19 | 開始されました | JMP Securities | Mkt Outperform |
| 2021-10-15 | 再開されました | BTIG Research | Buy |
| 2021-04-26 | 再開されました | Credit Suisse | Outperform |
| 2021-03-12 | アップグレード | Barclays | Underweight → Overweight |
| 2020-12-22 | 再開されました | H.C. Wainwright | Buy |
| 2020-08-03 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-06-01 | アップグレード | Guggenheim | Neutral → Buy |
| 2020-05-26 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-03-04 | 開始されました | Barclays | Underweight |
| 2019-12-19 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-12-18 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-11-21 | ダウングレード | Morgan Stanley | Equal-Weight → Underweight |
| 2019-11-20 | 再開されました | Guggenheim | Neutral |
| 2019-05-03 | アップグレード | Wedbush | Neutral → Outperform |
| 2019-04-12 | 開始されました | Guggenheim | Neutral |
| 2019-02-07 | アップグレード | Citigroup | Sell → Buy |
| 2019-02-07 | ダウングレード | Wedbush | Outperform → Neutral |
| 2019-02-06 | アップグレード | Raymond James | Underperform → Mkt Perform |
| 2019-02-04 | ダウングレード | Citigroup | Neutral → Sell |
| 2018-12-10 | ダウングレード | Raymond James | Outperform → Underperform |
| 2018-09-10 | 再開されました | BTIG Research | Buy |
| 2018-05-31 | 開始されました | Evercore ISI | Outperform |
| 2018-03-05 | 開始されました | H.C. Wainwright | Buy |
| 2017-03-31 | 開始されました | Raymond James | Outperform |
すべてを表示
Macrogenics Inc (MGNX) 最新ニュース
What makes MacroGenics Inc. stock price move sharplyOutstanding stock performance - jammulinksnews.com
What are MacroGenics Inc. company’s key revenue driversHigh-yield investments - jammulinksnews.com
Is MacroGenics Inc. a growth stock or a value stockSuperior return velocity - jammulinksnews.com
How volatile is MacroGenics Inc. stock compared to the marketExceptional trading results - jammulinksnews.com
What are the latest earnings results for MacroGenics Inc.Grow your wealth with proven stock picks - jammulinksnews.com
How strong is MacroGenics Inc. company’s balance sheetEntry Signal Growth Plan For Every Investor - jammulinksnews.com
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 24, 2024 in MacroGenics LawsuitMGNX - ACCESS Newswire
What institutional investors are buying MacroGenics Inc. stockPost Market Opportunities With High Returns - jammulinksnews.com
MacroGenics’ Prostate Cancer Study: A Potential Game-Changer? - TipRanks
Why MacroGenics Inc. stock attracts strong analyst attentionTriple Digit Return Stock Predictions Released - metal.it
MacroGenics’ Phase 2 Study: A Potential Game-Changer in Prostate Cancer Treatment? - TipRanks
RSI and MACD Indicate Shift in MacroGenics Inc. SentimentProven Entry Plan With Low Risk Shared - metal.it
Is MacroGenics Inc. Starting a New UptrendBuy Low Sell High Stock Watch Strategy in Focus - metal.it
MacroGenics’ Promising Study on Advanced Solid Tumors: Key Insights for Investors - TipRanks
Will MacroGenics Inc. see short term momentumWeekly Trend Watch with Market Signals - Newser
What the charts say about MacroGenics Inc. todayGrowth Summary Based on Market Positioning - Newser
Analyzing MacroGenics Inc. with multi timeframe chartsFree Trend Following Strategy With Stop Loss - Newser
How does MacroGenics Inc. generate profit in a changing economyAchieve breakthrough gains with expert advice - jammulinksnews.com
What catalysts could drive MacroGenics Inc. stock higher in 2025Invest confidently with real-time market updates - jammulinksnews.com
What is MacroGenics Inc. company’s growth strategyRealize consistent double-digit growth - jammulinksnews.com
Why is MacroGenics Inc. stock attracting strong analyst attentionAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
When is MacroGenics Inc. stock expected to show significant growthUnstoppable trading performance - jammulinksnews.com
How MacroGenics Inc. stock performs during market volatilityProven Return Strategy Execution - metal.it
Moving Average Trends for MacroGenics Inc. Stock: What They IndicateElite Stock Shortlist - Newser
MacroGenics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayFree Access to Investment Community - Newser
Is MacroGenics Inc. stock a good hedge against inflationFree Growth Investment Group - Newser
MacroGenics Inc. Stock Analysis and ForecastTremendous financial leverage - PrintWeekIndia
What drives MacroGenics Inc. stock priceExceptional earning trajectories - Autocar Professional
What analysts say about MacroGenics Inc. stockHigh-octane investment gains - PrintWeekIndia
Is MacroGenics Inc. a good long term investmentMarket-crushing profits - Autocar Professional
MacroGenics, Inc. (NASDAQ:MGNX) Surges 37% Yet Its Low P/S Is No Reason For Excitement - simplywall.st
MacroGenics, Inc. (NASDAQ:MGNX) Given Average Rating of “Hold” by Brokerages - Defense World
Macrogenics Inc (MGNX) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
0.15%
大文字化:
|
ボリューム (24 時間):